Ali S S, Elliott W H
Biochim Biophys Acta. 1975 Nov 21;409(2):249-57. doi: 10.1016/0005-2760(75)90159-9.
Rabbit liver microsomal preparations fortified with 0.1 mM NADPH effectively promote hydroxylation of [3beta-3H]- or [24-14C]allochenodeoxycholic acid or [5alpha,6alpha-3H2]5alpha-cholestane-3alpha,7alpha-diol to their respective 12alpha-hydroxyl derivatives in yields of about 25 or 65% in 60 min. Minor amounts of other products are formed from the diol. The requirements for activity of rabbit liver microsomal 12alpha-hydroxylase resemble those of rat liver microsomes. Of a number of enzyme inhibitors studied only p-chloromercuribenzoate demonstrated a marked ability to inhibit the reaction with either tritiated substrate. There was no difference in the quantity of product produced from the tritiated acid or the 14C-labeled acid. No clear sex difference was found in activity of the enzyme, nor was an appreciable difference noted in activity of the enzyme between mature and immature animals.
用0.1 mM NADPH强化的兔肝微粒体制剂能有效促进[3β-³H]-或[24-¹⁴C]别鹅去氧胆酸或[5α,6α-³H₂]5α-胆甾烷-3α,7α-二醇羟基化,在60分钟内分别生成其各自的12α-羟基衍生物,产率约为25%或65%。二醇会生成少量其他产物。兔肝微粒体12α-羟化酶的活性要求与大鼠肝微粒体相似。在研究的多种酶抑制剂中,只有对氯汞苯甲酸表现出显著抑制与两种氚标记底物反应的能力。由氚标记酸或¹⁴C标记酸产生的产物量没有差异。未发现该酶活性存在明显的性别差异,成熟动物与未成熟动物之间的酶活性也未观察到明显差异。